Articles Tagged With: COVID-19
-
COVID-19: Duration of Shedding of Transmissible Virus
Patients with COVID-19 were found, by culture, to shed replication-competent virus after an initial positive polymerase chain reaction test for median durations four to five days.
-
Paxlovid Rebound Concerns Are Overblown
A cohort of 483 high-risk patients was treated with nirmatrelvir/ritonavir for COVID-19. Two of the patients (0.4%) required hospitalization by day 30, and four patients (0.8%) experienced a rebound of symptoms (generally mild) at median of nine days after treatment. All resolved without additional COVID-19-directed therapy.
-
COVID-19 Rebound
Symptomatic and virologic recrudescence after treatment of patients with COVID-19 with nirmatrelvir/ritonavir (Paxlovid) — Paxlovid rebound — occurs in a very small percentage of patients and generally is mild and self-limited.
-
Immigrants Face Language Barriers and Other Challenges to Reproductive Health Access
More than 22 million non-citizens live in the United States — about 7% of the total U.S. population. Many do not have access to healthcare, including reproductive services. Immigrants — including refugees, those with permanent residency, and those who are undocumented — face additional challenges and barriers to reproductive care.
-
Telehealth Expands Contraceptive Access, but Some Youth Just Want Face-to-Face Care
A research review involving telemedicine-delivered contraceptive health services to female adolescents and young adults revealed that youth find these acceptable, but some reported a preference for in-person care.
-
Ethics Consults During Pandemic Inform Preparation for Future Crises
Lessons learned on ethics consults during the COVID-19 pandemic carry important implications for future disasters.
-
HRSA Compliance Exposes Hospitals to Liability and Fines
The Health Resources and Services Administration program that reimbursed providers for COVID-19-related treatment for uninsured patients was instrumental in helping hospitals survive the pandemic without excessive financial losses. But the federal government is looking at how that money was obtained and whether it was spent properly.
-
Answering Patient Questions About COVID-19
Wright State University Boonshoft School of Medicine formed an educational task force to educate clinicians and answer community members’ questions about all things COVID-19. Easily referenced resources on COVID-19 are essential for healthcare professionals in speaking with patients. Easy-to-navigate, dependable, up-to-date sources of information help serve patients requiring specific and timely answers to questions. Having a “go-to” list of resources can reduce confusion about COVID-19, making vaccination updates and other conversations more productive.
-
COVID-19 Pre-Exposure Prophylaxis
The combination of tixagevimab and cilgavimab (Evusheld) was demonstrated to be effective in the prevention of symptomatic COVID-19, but much remains to be learned as SARS-CoV-2 continues to evolve.
-
Who Can Receive the Non-mRNA COVID-19 Vaccine Now?
The FDA recently limited the use of the Janssen COVID-19 vaccine.